Back

Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of oesophageal cancer

Ganguli, P.; Colomina-Basanta, C.; Acha-Sagrado, A.; Misetic, H.; Armero-Pineiro, M.; Mendez, A.; Zahra, A.; Devonshire, G.; Kelly, G.; Freeman, A.; Green, M.; Nye, E.; Bichisecchi, A.; Bonfanti, P.; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, ; Rodriguez-Justo, M.; Spencer, J.; Fitzgerald, R. C.; Ciccarelli, F. D.

2024-08-08 cancer biology
10.1101/2024.01.24.576991 bioRxiv
Show abstract

CDKN2A is a tumour suppressor located in chromosome 9p21 and frequently lost in Barretts oesophagus (BO) and oesophageal adenocarcinoma (OAC). How CDKN2A and other 9p21 gene co-deletions affect OAC evolution remains understudied. We explored the effects of 9p21 loss in OACs and cancer progressor and non-progressor BOs with matched genomic, transcriptomic, and clinical data. Despite its cancer driver role, CDKN2A loss in BO prevents OAC initiation by counter-selecting subsequent TP53 alterations. 9p21 gene co-deletions predict poor patient survival in OAC but not BO through context-dependent effects on cell cycle, oxidative phosphorylation, and interferon response. Immune quantifications using bulk transcriptome, RNAscope and high-dimensional tissue imaging showed that IFNE loss reduces immune infiltration in BO but not OAC. Mechanistically, CDKN2A loss suppresses the maintenance of squamous epithelium, contributing to a more aggressive phenotype. Our study demonstrates context-dependent roles of cancer genes during disease evolution, with consequences for cancer detection and patient management.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.